{
  "patient_information": "The provided patient information includes an age of 40 years for a male individual. There are no recorded comorbidities or immunosuppression status. The vaccination history is also unspecified, and there is no allergy information available in the dataset.",
  "chief_complaint": "The patient's chief complaint is changes in both eyes that have been observed over the past four years.",
  "history_of_present_illness": "The patient's history of present illness reveals that they have noticed changes in their eyes for about four years, which include corneal opacities and subcutaneous nodules.",
  "exposure_and_epidemiology": "The exposure and epidemiology data includes information about residence and travel from Togo with recent travel to a village near a rapidly flowing river. There are small biting flies common near the river which is preferred breeding site for Simulium blackflies, indicating potential waterborne risks. However, there have been no reported sick contacts or outbreak context related to occupation.",
  "vitals": "The vital signs recorded are as follows: the temperature is not available, blood pressure is not available, heart rate is not available, respiratory rate is not available, and oxygen saturation is not available.",
  "physical_exam": "The physical examination revealed several notable findings. Skin changes included atrophic skin with a loss of elasticity, accompanied by multiple scratch marks. Additionally, corneal opacities were observed in both eyes. Furthermore, subcutaneous nodules were palpable over bony prominences such as the ribs and iliac crest.",
  "labs_and_diagnostics": "The provided data under the \"labs_and_diagnostics\" field includes several categories that are currently not available or have no values. These include CBC trends, key chemistry and coagulation tests, inflammatory markers, and microbiology serology PCR results.",
  "differential_diagnosis": "The most probable differential diagnosis for this condition, given the clinical symptoms and history of exposure to a swiftly moving river, is Onchocerciasis, also known as river blindness.",
  "management_and_clinical_course": "The patient was treated with ivermectin at a dosage of 150 Î¼g/kg STAT and then again after three months and one year. Supportive care procedures were not required. The patient responded well to the treatment, recovering fully by the sixth day without any complications being documented.",
  "final_diagnosis": "The final diagnosis is Onchocerciasis (river blindness), confirmed by positive serological tests for the Ov150 antigen and recombinant Ov16. Other potential diagnoses were ruled out based on the patient's clinical presentation, their exposure history, and the positive test results.",
  "disease_name_short": "The disease name short for Onchocerciasis is simply \"Onchocerciasis\"."
}